Drug class · Endocrine & metabolism

GLP-1 receptor agonists Drug Codes & NDCs

Drugs that activate the glucagon-like peptide-1 (GLP-1) receptor. The class includes injectable and oral products; tirzepatide is also listed here because it acts on both the GLP-1 and GIP receptors.

121 finished products listed with the FDA

FDA-listed products

Finished products in the GLP-1 receptor agonists class, A–Z by brand
ProductStrengthForm · routeLabelerProduct NDC
TrulicitydulaglutideDulaglutide .75 mg/.5mLInjection, SolutionSubcutaneousA-S Medication Solutions50090-3484
TrulicitydulaglutideDulaglutide 3 mg/.5mLInjection, SolutionSubcutaneousA-S Medication Solutions50090-5467
TrulicitydulaglutideDulaglutide .75 mg/.5mLInjection, SolutionSubcutaneousA-S Medication Solutions50090-6453
TrulicitydulaglutideDulaglutide 1.5 mg/.5mLInjection, SolutionSubcutaneousA-S Medication Solutions50090-6456
TrulicitydulaglutideDulaglutide 3 mg/.5mLInjection, SolutionSubcutaneousA-S Medication Solutions50090-6571
TrulicitydulaglutideDulaglutide 4.5 mg/.5mLInjection, SolutionSubcutaneousA-S Medication Solutions50090-7589
VictozaliraglutideLiraglutide 6 mg/mLInjectionSubcutaneousNovo Nordisk0169-4060
VictozaliraglutideLiraglutide 6 mg/mLInjectionSubcutaneousA-S Medication Solutions50090-2853
VictozaliraglutideLiraglutide 6 mg/mLInjectionSubcutaneousA-S Medication Solutions50090-4503
WegovysemaglutideSemaglutide 4 mg/1TabletOralNovo Nordisk Pharmaceutical Industries, LP0169-4404
WegovysemaglutideSemaglutide 9 mg/1TabletOralNovo Nordisk Pharmaceutical Industries, LP0169-4409
WegovysemaglutideSemaglutide 1.5 mg/1TabletOralNovo Nordisk Pharmaceutical Industries, LP0169-4415
WegovysemaglutideSemaglutide 25 mg/1TabletOralNovo Nordisk Pharmaceutical Industries, LP0169-4425
WegovysemaglutideSemaglutide 1 mg/.5mLInjection, SolutionSubcutaneousNovo Nordisk Pharmaceutical Industries, LP0169-4501
WegovysemaglutideSemaglutide .5 mg/.5mLInjection, SolutionSubcutaneousNovo Nordisk Pharmaceutical Industries, LP0169-4505
WegovysemaglutideSemaglutide 1.7 mg/.75mLInjection, SolutionSubcutaneousNovo Nordisk Pharmaceutical Industries, LP0169-4517
WegovysemaglutideSemaglutide 2.4 mg/.75mLInjection, SolutionSubcutaneousNovo Nordisk Pharmaceutical Industries, LP0169-4524
WegovysemaglutideSemaglutide .25 mg/.5mLInjection, SolutionSubcutaneousNovo Nordisk Pharmaceutical Industries, LP0169-4525
WegovysemaglutideSemaglutide 7.2 mg/.75mLInjection, SolutionSubcutaneousNovo Nordisk Pharmaceutical Industries, LP0169-4572
WegovysemaglutideSemaglutide 3.2 mg/mLInjection, SolutionSubcutaneousNovo Nordisk Pharmaceutical Industries, LP0169-4915
WegovysemaglutideSemaglutide .25 mg/.5mLInjection, SolutionSubcutaneousA-S Medication Solutions50090-5824
Xultophy 100/3.6insulin degludec and liraglutideInsulin degludec 100 [iU]/mL; Liraglutide 3.6 mg/mLInjection, SolutionSubcutaneousNovo Nordisk0169-2911
ZepboundtirzepatideTirzepatide 2.5 mg/.5mLInjection, SolutionSubcutaneousEli Lilly and Company0002-0152
ZepboundtirzepatideTirzepatide 5 mg/.5mLInjection, SolutionSubcutaneousEli Lilly and Company0002-0243
ZepboundtirzepatideTirzepatide 7.5 mg/.5mLInjection, SolutionSubcutaneousEli Lilly and Company0002-1214

Med-Code uses cookies for analytics and advertising. You can accept or reject them; the site works either way. Privacy Policy.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in